Mesalazine (Systemic) vs Risankizumab
National NHS prescribing compared (Prescription Cost Analysis)
Mesalazine (Systemic) was dispensed 136,369.0× as often as Risankizumab in March 2026 — 136,369 items versus 1 in England.
136,369items
Mesalazine (Systemic) · March 2026
NHSBSA Prescription Cost Analysis
1items
Risankizumab · March 2026
NHSBSA Prescription Cost Analysis
Figure 1. Mesalazine (Systemic) versus Risankizumab: national items dispensed by month
▬ Mesalazine (Systemic) · ╌ Risankizumab
Source: NHSBSA Prescription Cost Analysis, to March 2026
| Measure | Mesalazine (Systemic) | Risankizumab |
|---|---|---|
| Items, March 2026 | 136,369 | 1 |
| Items, last 12 months | 1,626,325 | 1 |
| Net ingredient cost, March 2026 | £7,840,163 | £3,326 |
See the full profile for Mesalazine (Systemic) or Risankizumab.